- Home
- FXNC vs INBX Comparison
FXNC vs INBX Comparison
Compare FXNC & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- INBX
- Stock Information
- Founded
- FXNC 1907
- INBX 2010
- Country
- FXNC United States
- INBX United States
- Employees
- FXNC N/A
- INBX N/A
- Industry
- FXNC Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- INBX Health Care
- Exchange
- FXNC Nasdaq
- INBX Nasdaq
- Market Cap
- FXNC 201.9M
- INBX 168.1M
- IPO Year
- FXNC N/A
- INBX 2020
- Fundamental
- Price
- FXNC $19.61
- INBX $11.18
- Analyst Decision
- FXNC Strong Buy
- INBX Hold
- Analyst Count
- FXNC 1
- INBX 1
- Target Price
- FXNC $21.00
- INBX N/A
- AVG Volume (30 Days)
- FXNC 18.2K
- INBX 97.5K
- Earning Date
- FXNC 04-30-2025
- INBX 05-20-2025
- Dividend Yield
- FXNC 3.17%
- INBX 7.56%
- EPS Growth
- FXNC N/A
- INBX N/A
- EPS
- FXNC 0.70
- INBX 112.62
- Revenue
- FXNC $64,346,999.00
- INBX $200,000.00
- Revenue This Year
- FXNC $57.36
- INBX N/A
- Revenue Next Year
- FXNC $4.25
- INBX N/A
- P/E Ratio
- FXNC $27.87
- INBX $0.10
- Revenue Growth
- FXNC 31.48
- INBX N/A
- 52 Week Low
- FXNC $14.75
- INBX $10.80
- 52 Week High
- FXNC $26.97
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- FXNC 43.62
- INBX 38.27
- Support Level
- FXNC $19.29
- INBX $10.90
- Resistance Level
- FXNC $19.74
- INBX $12.60
- Average True Range (ATR)
- FXNC 0.68
- INBX 0.86
- MACD
- FXNC 0.12
- INBX -0.03
- Stochastic Oscillator
- FXNC 28.79
- INBX 14.28
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.